Search results for "HIV"

showing 10 items of 1527 documents

Cytokine-mediated regulation of monocyte/macrophage cytotoxicity in human immunodeficiency virus-1 infection.

1992

Monocyte/macrophage-mediated tumor cytotoxicity was studied in patients infected with human immunodeficiency virus-1 (HIV-1) at various stages [Center for disease control (CDC) classification] of the disease. using the P-815 tumor cell line as target cells, the results demonstrated reduced monocyte/macrophage cytotoxicity early in HIV-1-related disease (CDCIII, P0.01). This cellular dysfunction sustained during the progression of the disease. Evidence could be presented that neither exogenous application of macrophage-stimulating cytokines (e.g. interferons) nor their endogenous induction in vitro restored monocyte/macrophage cytotoxicity. However, enhanced tumor necrosis factor (TNF)-alpha…

Microbiology (medical)AdultCytotoxicity Immunologicmedicine.medical_treatmentImmunologyHIV InfectionsBiologyVirusMonocytesmedicineTumor Cells CulturedImmunology and AllergyMacrophageHumansProstaglandin E2CytotoxicityCells CulturedTumor Necrosis Factor-alphaMonocyteInterleukinsMacrophagesGeneral MedicineMiddle AgedIn vitroCytokinemedicine.anatomical_structureImmunologyHIV-1CytokinesTumor necrosis factor alphaInterferonsmedicine.drugMedical microbiology and immunology
researchProduct

Oral leishmaniasis in an HIV-infected patient.

2000

As in most countries in the Mediterranean basin, leishmaniasis is endemic in Italy, where it has visceral (VL) and cutaneous (CL) forms caused by viscerotropic and dermotropic strains of Leishmania infantum, respectively. With the spread of the acquired immunodeficiency syndrome (AIDS) epidemic, the number of coinfections with Leishmania and human immunodeficiency virus (HIV) is increasing. Between 35% and 50% of the adult VL cases diagnosed annually in Sicily from 1991 to 1995 were related to HIV [1]; although cases of coinfection have been reported in 28 countries worldwide, the majority of these cases (1440 from 1990 to 1998) have been notified in four countries (Spain, Italy, France, Po…

Microbiology (medical)AdultLeishmaniasis MucocutaneousMaleHIV InfectionsAcquired immunodeficiency syndrome (AIDS)medicineHumansSidaLeishmaniasisbiologyLamivudineLeishmaniasisGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaVirologyInfectious DiseasesImmunologyCoinfectionFemaleViral diseaseLeishmania infantumMouth Diseasesmedicine.drugEuropean journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology
researchProduct

Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishman…

2007

Background To overcome some of the limitations of conventional microbiologic techniques, polymerase chain reaction (PCR)-based assays are proposed as useful tools for the diagnosis of visceral leishmaniasis. Patients and methods A comparative study using conventional microbiologic techniques (i.e., serologic testing, microscopic examination, and culture) and a Leishmania species-specific PCR assay, using peripheral blood and bone marrow aspirate samples as templates, was conducted during an 8-year period. The study cohort consisted of 594 Italian immunocompetent (adult and pediatric) and immunocompromised (adult) patients experiencing febrile syndromes associated with hematologic alteration…

Microbiology (medical)AdultMalePathologymedicine.medical_specialtyHepatosplenomegalyHIV InfectionsPolymerase Chain ReactionSensitivity and Specificitylaw.inventionSerologyImmunocompromised HostlawBone MarrowBiopsymedicineAnimalsHumansSerologic TestsProspective StudiesChildPolymerase chain reactionAgedLeishmaniamedicine.diagnostic_testAIDS-Related Opportunistic Infectionsbusiness.industryInfantLeishmaniasisMiddle Agedmedicine.diseaseInfectious Diseasesmedicine.anatomical_structureVisceral leishmaniasisPCRItalyChild PreschoolImmunologyLeishmaniasis VisceralFemaleBone marrowViral diseasemedicine.symptombusinessAlgorithms
researchProduct

Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired h…

2008

Objective: To estimate the incidence of newly acquired syphilis (n-syphilis) and hepatitis B infection (n-hepatitis B) in I.Co.N.A. and to evaluate the impact of HAART, calendar date and risk group. Methods: Cohort study: Incidence was calculated by person-years analyses. Poisson regression was used for the multivariate model. Results: The rate of n-syphilis was 23.4/1,000 PYFU and it increased over time; HIV transmission risk was the most important predictor: men who have sex with men (MSM) had a considerable higher risk (RR 5.92, 95% CI 2.95-12.13 vs IDU/exIDU, p < 0.0001). The rate of n-hepatitis B was 12.2/1,000 PYFU; it declined in recent years and halved per 10 years age. Patients wit…

Microbiology (medical)AdultMalemedicine.medical_specialtyHBsAgHAARTPopulationImmunologySexually Transmitted DiseasesHIV InfectionsLower riskRegression AnalysiMen who have sex with menCohort StudiesAcquired immunodeficiency syndrome (AIDS)Internal medicineAntiretroviral Therapy Highly ActivemedicineHumansHIV InfectionPoisson DistributionSyphilisHomosexuality MaleeducationMultivariate AnalysiSexually Transmitted Diseaseeducation.field_of_studybusiness.industryIncidence (epidemiology)Incidencevirus diseasesHIVGeneral MedicineHepatitis Bmedicine.diseaseHepatitis BInfectious DiseasesSyphiliItalyImmunologyCohortMultivariate AnalysisHIV-1Regression AnalysisFemaleCohort StudiebusinessHumanInfection
researchProduct

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cry…

2003

With the spread of the human immunodeficiency virus in the early 1980s, cryptosporidiosis was regarded as an AIDS-defining disease. As an opportunistic pathogen, the intestinal parasite Cryptosporidium parvum became an important cause of chronic diarrhoea, leading to high morbidity and mortality in immunocompromised patients. To date, no effective chemotherapy is available. With the introduction of protease inhibitors (PIs) in highly active antiretroviral therapy (HAART), the incidence of cryptosporidiosis in AIDS patients has declined substantially in western countries. We have therefore tested the effect of five PIs used in HAART on the excystation, invasion and development of the parasit…

Microbiology (medical)Cell SurvivalParomomycinvirusesCryptosporidiosisParomomycinHost-Parasite InteractionsMicrobiologyImmunoenzyme Techniquesimmune system diseasesIndinavirAntiretroviral Therapy Highly ActiveCell Line TumormedicineAnimalsHumansPharmacology (medical)Protease inhibitor (pharmacology)AmebicidesAntibacterial agentCryptosporidium parvumPharmacologybiologyvirus diseasesDrug SynergismHIV Protease Inhibitorsbiochemical phenomena metabolism and nutritionbiology.organism_classificationVirologyInfectious DiseasesCryptosporidium parvumNelfinavirRitonavirSaquinavirmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz.

2014

Objectives Growing evidence associates the non-nucleoside reverse transcriptase inhibitor efavirenz with several adverse events. Newer antiretrovirals, such as the integrase inhibitor raltegravir, the non-nucleoside reverse transcriptase inhibitor rilpivirine and the protease inhibitor darunavir, claim to have a better toxicological profile than efavirenz while producing similar levels of efficacy and virological suppression. The objective of this study was to determine the in vitro toxicological profile of these three new antiretrovirals by evaluating their effects on the mitochondrial and cellular parameters altered by efavirenz in hepatocytes and neurons. Methods Hep3B cells and primary …

Microbiology (medical)CyclopropanesEfavirenzAnti-HIV AgentsIntegrase inhibitorBiologyMitochondrionPharmacologychemistry.chemical_compoundCell Line TumorRaltegravir PotassiumDrug Resistance ViralNitrilesmedicineAnimalsHumansPharmacology (medical)DarunavirCells CulturedDarunavirPharmacologyNeuronsSulfonamidesReverse-transcriptase inhibitorRilpivirinemedicine.diseaseRaltegravirPyrrolidinonesBenzoxazinesMitochondriaRatsMitochondrial toxicityInfectious DiseasesPyrimidineschemistryRilpivirineAlkynesHepatocytesReverse Transcriptase Inhibitorsmedicine.drugThe Journal of antimicrobial chemotherapy
researchProduct

A case of spotted fever rickettsiosis in a human immunodeficiency virus-positive patient.

2013

Microbiology (medical)DNA BacterialMaleHuman Immunodeficiency Virus Positivebusiness.industryCoinfectionHIV InfectionsGeneral MedicineExanthemaMiddle Agedmedicine.diseaseBoutonneuse FeverMicrobiologyVirologyHepatitis CSpotted feverRickettsia conoriiRickettsiosisTick-Borne DiseasesDoxycyclineImmunologymedicineHumansbusinessJournal of medical microbiology
researchProduct

Efavirenz and the CNS: what we already know and questions that need to be answered

2015

The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the multidrug regimens used to treat HIV infection, in accordance with its well-demonstrated antiretroviral efficacy and favourable pharmacokinetics. However, growing concern about its adverse effects has sometimes led to efavirenz being replaced by other drugs in the initial treatment selection or to switching of therapy to efavirenz-free regimens in experienced patients. Neurological and neuropsychiatric reactions are the manifestations most frequently experienced by efavirenz-treated patients and range from transitory effects, such as nightmares, dizziness, insomnia, nervousness and lack of conc…

Microbiology (medical)DrugCentral Nervous SystemCyclopropanesPsychosismedicine.medical_specialtyEfavirenzAnti-HIV Agentsmedia_common.quotation_subjectHIV InfectionsPolymorphism Single Nucleotidechemistry.chemical_compoundimmune system diseasesCentral Nervous System DiseasesAntiretroviral Therapy Highly ActivemedicineAnimalsCytochrome P-450 Enzyme InhibitorsHumansPharmacology (medical)Adverse effectIntensive care medicineSuicidal ideationmedia_commonPharmacologybusiness.industryNeurotoxicityvirus diseasesmedicine.diseaseBenzoxazinesCytochrome P-450 CYP2B6Disease Models AnimalInfectious DiseaseschemistryPharmacogeneticsAlkynesReverse Transcriptase Inhibitorsmedicine.symptomCNSEfavirenzbusinessNeurocognitivePharmacogenetics
researchProduct

Producción científica, colaboración y ámbitos de investigación en Enfermedades Infecciosas y Microbiología Clínica (2003–2007)

2010

Introduction: Collaboration is essential for biomedical research. The Carlos III Health Institute (the Spanish national public organization responsible for promoting biomedical research) has encouraged scientific collaboration by promoting Thematic Networks and Cooperative Research Centres. Scientific collaboration in Enfermedades Infecciosas y Microbiologia Clinica journal is investigated. Methods: Papers published in Enfermedades Infecciosas y Microbiologia Clinica in the period 2002-2007 have been identified. Bibliometrics and Social Network Analysis methods have been carried out in order to quantify and characterise scientific collaboration and research areas. Results: A total of 805 pa…

Microbiology (medical)GerontologyPublic organizationResearch groupsbusiness.industryResearch areasCooperative researchHuman immunodeficiency virus (HIV)Library scienceBibliometricsmedicine.diseasemedicine.disease_causeAcquired immunodeficiency syndrome (AIDS)MedicinebusinessCitationEnfermedades Infecciosas y Microbiología Clínica
researchProduct

Tumornekrosefaktor und Interferon als prognostische Marker der HIV-Infektion

1991

Peripheral blood cells were obtained from patients at different stages of their human immunodeficiency virus (HIV) infection. It was found that the capacity to generate interferon alpha was reduced already at Walter Reed stage 2 (WR) while the interferon gamma capacity remained largely unaffected until WR stage 4. Endogenous tumor necrosis factor (TNF) alpha production increased as the HIV disease progressed. The data obtained add to our knowledge on destruction of the immune system by the HIV. Moreover TNF and acid labile interferon alpha might contribute to HIV replication and disease progression. Nevertheless the tests performed are too time-consuming to be introduced into routine analys…

Microbiology (medical)Human immunodeficiency virus (HIV)Alpha (ethology)Alpha interferonEndogenyGeneral MedicineBiologymedicine.disease_causeVirologyInfectious DiseasesImmune systemInterferonImmunologymedicineTumor necrosis factor alphaInterferon gammamedicine.drugInfection
researchProduct